Drug-induced lupus
Drug-induced lupus erythematosus (DILE) is an important differential to consider in a clinical setting of mild lupus. Numerous drugs ranging from the classically described procainamide and hydralazine to novel biological agents such as anti-tumor necrosis factors and immune checkpoint inhibitors are...
Saved in:
Main Author: | Kavadichanda Chengappa G |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=5;spage=10;epage=18;aulast=G |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review
by: Beata Mayer, et al.
Published: (2025-12-01) -
Impact of Sex on Infection Risk in Patients with Systemic Lupus Erythematosus
by: R. Borrelli, et al.
Published: (2025-01-01) -
Drug reaction with eosinophilia and systemic symptoms syndrome
by: K C Shanoj, et al.
Published: (2019-01-01) -
Immune modulation effects of curcumin in pristane-induced lupus mice
by: Handono Kalim, et al.
Published: (2017-01-01) -
Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center
by: Keerthi Talari, et al.
Published: (2017-01-01)